UBS Reiterates Buy Rating on Eli Lilly (LLY) Following Strong Q4, Upside Guidance
Tweet Send to a Friend
UBS analyst Michael Yee reiterated a Buy rating and $1,250.00 price target on Eli Lilly (NYSE: LLY).The analyst commented, "LLY ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
